APA

Tcheng J. E., Kandzari D. E., Grines C. L., Cox D. A., Effron M. B., Garcia E., Griffin J. J., Guagliumi G., Stuckey T., Turco M., Fahy M., Lansky A. J., Mehran R. & Stone G. W. (20030930). Benefits and risks of abciximab use in primary angioplasty for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial. : Circulation.

Chicago

Tcheng James E, Kandzari David E, Grines Cindy L, Cox David A, Effron Mark B, Garcia Eulogio, Griffin John J, Guagliumi Giulio, Stuckey Thomas, Turco Mark, Fahy Martin, Lansky Alexandra J, Mehran Roxana and Stone Gregg W. 20030930. Benefits and risks of abciximab use in primary angioplasty for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial. : Circulation.

Harvard

Tcheng J. E., Kandzari D. E., Grines C. L., Cox D. A., Effron M. B., Garcia E., Griffin J. J., Guagliumi G., Stuckey T., Turco M., Fahy M., Lansky A. J., Mehran R. and Stone G. W. (20030930). Benefits and risks of abciximab use in primary angioplasty for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial. : Circulation.

MLA

Tcheng James E, Kandzari David E, Grines Cindy L, Cox David A, Effron Mark B, Garcia Eulogio, Griffin John J, Guagliumi Giulio, Stuckey Thomas, Turco Mark, Fahy Martin, Lansky Alexandra J, Mehran Roxana and Stone Gregg W. Benefits and risks of abciximab use in primary angioplasty for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial. : Circulation. 20030930.